GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

NCT02243371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Previously Treated Metastatic Adenocarcinoma of the Pancreas

Interventions

BIOLOGICAL: CRS-207
BIOLOGICAL: CRS-207
DRUG: nivolumab
BIOLOGICAL: GVAX
DRUG: CY

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]